查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
重病下肢缺血治療市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1140626

重病下肢缺血治療市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Critical Limb Ischemia Treatment Market (Treatment: Medications, and Devices: Embolic Protection Devices and Peripheral Dilatation System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 211 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球重病下肢缺血治療市場相關調查，提供市場概要，以及2022年～2031年的預測，不同治療，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 市場動態
    • 促進因素與推動因素的概述分析
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球重病下肢缺血治療市場收益預測(100萬美元)，2017年～2027年
  • 全球重病下肢缺血治療市場預測

第5章 市場預測

  • 開發平台分析
  • 主要的產業活動
  • 設備的法規情景
  • 世界/地區的危急性肢體缺血的盛行率
  • 參與計劃的主要的研究機關
  • 技術的進步

第6章 全球重病下肢缺血治療市場分析，不同治療

  • 主要調查結果
  • 簡介
  • 全球重病下肢缺血治療市場價值與佔有率魅力分析，不同治療
  • 全球重病下肢缺血治療市場預測，不同治療
    • 設備
    • 藥物
  • 全球重病下肢缺血治療市場分析，不同治療

第7章 全球重病下肢缺血治療市場分析，各地區

  • 各國全球重病下肢缺血治療市場Scenario
  • 全球重病下肢缺血治療市場價值與佔有率魅力分析，各地區
  • 全球重病下肢缺血治療市場預測，各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第8章 北美的重病下肢缺血治療市場分析

第9章 歐洲的重病下肢缺血治療市場分析

第10章 亞太地區的重病下肢缺血治療市場分析

第11章 南美的重病下肢缺血治療市場分析

第12章 中東·非洲的重病下肢缺血治療市場分析

第13章 競爭情形

  • 競爭矩陣
  • 企業簡介
    • Medtronic plc
    • Boston Scientific Corporation
    • Cesca Therapeutics, Inc.
    • Abbott Laboratories
    • Pluristem Therapeutics, Inc.
    • Rexgenero Ltd.
    • LimFlow SA
    • Micro Medical Solutions
    • Cardiovascular Systems, Inc.
Product Code: TMRGL2770

The report provides revenue of the global critical limb ischemia treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global critical limb ischemia treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the critical limb ischemia treatment market.

The report delves into the competitive landscape of the global critical limb ischemia treatment market. Key players operating in the global critical limb ischemia treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global critical limb ischemia treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers and Restraints Snapshot Analysis
    • 4.2.2. Drivers
    • 4.2.3. Restraints
    • 4.2.4. Opportunity
  • 4.3. Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2017-2027
  • 4.4. Global Critical Limb Ischemia Treatment Market Outlook

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Key Industry Events
  • 5.3. Regulatory Scenario for Device
  • 5.4. Prevalence of Critical Limb Ischemia Globally/Region
  • 5.5. Major Research Institutes Involved
  • 5.6. Technological Advancement

6. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 6.4. Global Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 6.4.1. Devices
    • 6.4.2. Medication
  • 6.5. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment

7. Global Critical Limb Ischemia Treatment Market Analysis, by Region

  • 7.1. Global Critical Limb Ischemia Treatment Market Scenario, by Country
  • 7.2. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Region
  • 7.3. Global Critical Limb Ischemia Treatment Market Forecast, by Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa

8. North America Critical Limb Ischemia Treatment Market Analysis

  • 8.1. Key Findings
  • 8.2. North America Critical Limb Ischemia Treatment Market Overview
  • 8.3. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country
  • 8.4. North America Critical Limb Ischemia Treatment Market Forecast, by Country
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 8.6. North America Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 8.6.1. Devices
    • 8.6.2. Medication

9. Europe Critical Limb Ischemia Treatment Market Analysis

  • 9.1. Key Findings
  • 9.2. Europe Critical Limb Ischemia Treatment Market Overview
  • 9.3. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 9.4. Europe Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. U.K.
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 9.6. Europe Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 9.6.1. Devices
    • 9.6.2. Medication

10. Asia Pacific Critical Limb Ischemia Treatment Market Analysis

  • 10.1. Key Findings
  • 10.2. Asia Pacific Critical Limb Ischemia Treatment Market Overview
  • 10.3. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 10.4. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 10.6. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 10.6.1. Devices
    • 10.6.2. Medication

11. Latin America Critical Limb Ischemia Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. Latin America Critical Limb Ischemia Treatment Market Overview
  • 11.3. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.4. Latin America Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 11.6. Latin America Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 11.6.1. Devices
    • 11.6.2. Medication

12. Middle East & Africa Critical Limb Ischemia Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Middle East & Africa Critical Limb Ischemia Treatment Market Overview
  • 12.3. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.4. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
  • 12.6. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Treatment
    • 12.6.1. Devices
    • 12.6.2. Medication

13. Competition Landscape

  • 13.1. Competition Matrix
  • 13.2. Company Profiles
    • 13.2.1. Medtronic plc
      • 13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.1.2. Product Portfolio
      • 13.2.1.3. SWOT Analysis
      • 13.2.1.4. Strategic Overview
    • 13.2.2. Boston Scientific Corporation
      • 13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.2.2. Product Portfolio
      • 13.2.2.3. SWOT Analysis
      • 13.2.2.4. Strategic Overview
    • 13.2.3. Cesca Therapeutics, Inc.
      • 13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.3.2. Product Portfolio
      • 13.2.3.3. SWOT Analysis
      • 13.2.3.4. Strategic Overview
    • 13.2.4. Abbott Laboratories
      • 13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.4.2. Product Portfolio
      • 13.2.4.3. SWOT Analysis
      • 13.2.4.4. Strategic Overview
    • 13.2.5. Pluristem Therapeutics, Inc.
      • 13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.5.2. Product Portfolio
      • 13.2.5.3. SWOT Analysis
      • 13.2.5.4. Strategic Overview
    • 13.2.6. Rexgenero Ltd.
      • 13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.6.2. Product Portfolio
      • 13.2.6.3. SWOT Analysis
      • 13.2.6.4. Strategic Overview
    • 13.2.7. LimFlow SA
      • 13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.7.2. Product Portfolio
      • 13.2.7.3. SWOT Analysis
      • 13.2.7.4. Strategic Overview
    • 13.2.8. Micro Medical Solutions
      • 13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.8.2. Product Portfolio
      • 13.2.8.3. SWOT Analysis
      • 13.2.8.4. Strategic Overview
    • 13.2.9. Cardiovascular Systems, Inc.
      • 13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.9.2. Product Portfolio
      • 13.2.9.3. SWOT Analysis
      • 13.2.9.4. Strategic Overview

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 03: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 04: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 05: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 06: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Region, 2022-2031
  • Table 07: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country, 2022-2031
  • Table 08: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 09: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
  • Table 10: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
  • Table 11: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
  • Table 12: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 13: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 14: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
  • Table 15: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
  • Table 16: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
  • Table 17: Asia Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 18: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 19: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
  • Table 20: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
  • Table 21: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
  • Table 22: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 23: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 24: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
  • Table 25: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
  • Table 26: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
  • Table 27: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 28: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
  • Table 29: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
  • Table 30: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System,
  • Table 31: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
  • Table 32: Medtronic plc, Business Overview
  • Table 33: Boston Scientific Corporation Product Offerings
  • Table 34: Cesca Therapeutics Inc., Products & Services Offered
  • Table 35: Abbott Laboratories, Business Overview
  • Table 36: Pluristem Therapeutics Inc., Products & Services Offered
  • Table 37: Rexgenero Ltd, Products & Services Offered
  • Table 38: LimFlow SA, Products & Services Offered
  • Table 39: Micro Medical Solutions, Products & Services Offered
  • Table 40: Cardiovascular Systems, Inc., Products & Services Offered

List of Figures

  • Figure 01: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) and Distribution, by Region, 2021 and 2031
  • Figure 02: Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2022-2031
  • Figure 03: Global Critical Limb Ischemia Treatment Market Value Share, by Treatment, 2021
  • Figure 04: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2021
  • Figure 05: U.S. FDA Medical Devices Approval Criteria
  • Figure 06: Classification of Medical Devices
  • Figure 07: European Approval for Medical Devices - Regulatory Pathway (Class IIb Devices only)
  • Figure 08: Regulatory Approval Process - U.S.
  • Figure 09: Regulatory Approval Process - Europe
  • Figure 10: Regulatory Approval Process - Japan
  • Figure 11: Prevalence of Critical Limb Ischemia Globally/Region
  • Figure 12: Global Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 13: Global Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 14: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2022-2031
  • Figure 15: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Medication, 2022-2031
  • Figure 16: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2021 and 2031
  • Figure 17: Global Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 19: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 20: North America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 21: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 22: North America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 23: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 24: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 25: Europe Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 26: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 27: Europe Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 28: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 29: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 30: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 31: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 32: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 33: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 34: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 35: Latin America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 37: Latin America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 38: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 39: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 40: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 41: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
  • Figure 42: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 43: Medtronic plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 44: Medtronic plc, Breakdown of Net Sales (%), by Geography, 2021
  • Figure 45: Medtronic plc, Breakdown of Net Sales (%), by Business Segment, 2021
  • Figure 46: Medtronic plc, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 47: Boston Scientific Corporation, Revenue (US$ Bn) and Y-o-Y Growth (%), 2018-2021
  • Figure 48: Boston Scientific Corporation, Breakdown of Net Sales, by Region, 2021
  • Figure 49: Boston Scientific Corporation, Breakdown of Net Sales, by Business Segment, 2021
  • Figure 50: Cesca Therapeutics Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2018-2021
  • Figure 51: Cesca Therapeutics Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 52: Cesca Therapeutics Inc. Breakdown of Net Sales, by Region, 2021
  • Figure 53: Cesca Therapeutics Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 54: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 55: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2018-2021
  • Figure 56: Abbott Laboratories, Breakdown of Net Sales, by Countries, 2021
  • Figure 57: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2021
  • Figure 58: Cardiovascular Systems, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
  • Figure 59: Cardiovascular Systems, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2018-2021